less land expenses and legal fee. Loss from change in fair value of biological assets : The subsidiary (UPOIC) realized loss from change in fair value of biological assets of Baht 4.6 million (Q1/2019
quarter ended June 30, 2020, the Group had net loss attributable to equity holders of the Company amounting to Baht 123.6 million which increased by 34.2% from the same period of previous year. Total
354,032 38,198 10.8 Selling and distribution expenses 104,588 106,427 (1,839) (1.7) 95,785 93,788 1,997 2.1 Administrative expenses 180,753 174,720 6,033 3.5 131,619 123,826 7,793 6.3 Loss on impairment of
caused, revenue from sales of domestic and export decreased about 11% and 22% respectively. Analysis of Loss of company and its subsidiaries The Q1/2020, the company and its subsidiaries have loss for the
caused, revenue from sales of domestic and export decreased about 30% and 9% respectively. Analysis of Loss of company and its subsidiaries The Q2/2020, the company and its subsidiaries have loss for the
/2020 ended June 30, 2020 via electronic system. to the Stock Exchange of Thailand. It appears that the operating results of the said period has a net loss of 35.39 million baht, but in the same period of
appears that the operating results of the said period had a net loss of 58.60 million baht. But in the same period of the previous year had a net loss of 53.21 million baht and a net loss increased from the
results of the said period had a net loss of 68.06 million baht, but in the same period of the previous year there was a net loss of 131.85 million baht and a decrease in net loss from the same period of
) (90.64%) (1,665.17) (90.64%) (346.17) (20.79%) NRV 0.00 0.00% (3.35) (0.18%) (3.35) (100.00%) Cost of Service 0.00 0.00% (10.35) (212.07%) (10.35) (100.00%) Gross Profit (Loss) 136.25 9.36% 163.14 8.86
appears that the operating results with a net loss of 5.21 million baht. But in the same period of the previous year there was a net loss of 24.42 million baht. There was net loss decreased 19.21 million